about
Treatment of portal hypertensionSodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study.Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure.N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive ratsTherapeutic potential of targeting the renin angiotensin system in portal hypertension.Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats.Non-selective beta-blockers are not associated with serious infections in veterans with cirrhosis.Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension.Current Management Strategies for Acute Esophageal Variceal Hemorrhage.Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis.Mapping metabolic brain activity in three models of hepatic encephalopathy.Small-for-Size Syndrome: Bridging the Gap Between Liver Transplantation and Graft Recovery.Glutamine prevents oxidative stress in a model of portal hypertensionImmediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis.Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis.
P2860
Q34265176-DF9795B8-B928-42BA-9C1F-829AC9B9A41DQ34350388-EA5A6466-5323-4838-A0BD-BAC2750F3AEBQ34558284-88044824-B374-4225-AE2B-F2EB2B54AF9FQ36290381-5F6D7DDA-098E-4B7F-B44E-3110C9F37BD9Q36769062-4D04BB88-C616-4B98-AFB7-EE684FF48456Q36997029-00BB0435-1672-43C9-8EDD-C0AF718A1C32Q37049604-465D13E7-E125-4257-A07B-9D67C75BE938Q37604322-585E32A9-4508-488C-8F29-33BF908AFDB8Q38222435-A92E045C-C0BA-41C8-AE99-7B53796F77EAQ38618343-51F7D196-A9B7-4D16-B0F6-1AEFD0BC8381Q39447593-CA9ECDAA-4E78-4CC4-B468-9D0D9DB528F2Q40113551-7690274D-D60B-4FCD-98A6-96FCB80376D9Q40976036-C08CE0B8-68C2-46C9-B4B8-5081CEFA1785Q46498520-228BE9BE-0588-4B56-944F-BA1792986814Q50242973-BADE6869-BD2B-4466-AC84-AC123BE5AC12Q55038505-04073C03-4EC6-47F1-9895-4F42135DD3E1
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical pharmacology of portal hypertension.
@ast
Clinical pharmacology of portal hypertension.
@en
Clinical pharmacology of portal hypertension.
@nl
type
label
Clinical pharmacology of portal hypertension.
@ast
Clinical pharmacology of portal hypertension.
@en
Clinical pharmacology of portal hypertension.
@nl
prefLabel
Clinical pharmacology of portal hypertension.
@ast
Clinical pharmacology of portal hypertension.
@en
Clinical pharmacology of portal hypertension.
@nl
P2860
P1476
Clinical pharmacology of portal hypertension.
@en
P2093
Cecilia Miñano
Guadalupe Garcia-Tsao
P2860
P304
P356
10.1016/J.GTC.2010.08.015
P577
2010-09-01T00:00:00Z